NCT04879914View on ClinicalTrials.gov

Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
Inflammatory Bowel DiseasesIrritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Butyrate

3 cps/die 300 mg/cps

DIETARY_SUPPLEMENT

Placebo

3 cps/die 300 mg/cps

Trial Locations (1)

35128

Edoardo Vinvenzo Savarino, Padua

All Listed Sponsors
lead

University of Padova

OTHER

NCT04879914 - Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter